Valuation: Lonza Group AG

Market Cap 39.24B 47.56B 41.74B 35.87B 67.04B 4,556B 67.53B 471B 183B 2,323B 179B 175B 7,531B P/E 2026 *
32.8x
P/E 2027 * 27.4x
Enterprise Value 42.03B 50.95B 44.72B 38.43B 71.81B 4,880B 72.34B 505B 196B 2,488B 191B 187B 8,067B EV / Sales 2026 *
5.9x
EV / Sales 2027 * 5.27x
Free-Float
99.36%
Yield 2026 *
0.99%
Yield 2027 * 1.14%
1 day-0.18%
1 week+4.35%
Current month-2.57%
1 month-5.13%
3 months+9.05%
6 months+20.20%
Current year+4.46%
1 week 543.8
Extreme 543.8
565
1 month 527
Extreme 527
597.8
Current year 454.6
Extreme 454.6
597.8
1 year 454.6
Extreme 454.6
597.8
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
779.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 54 2021-11-30
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Director/Board Member 67 2016-04-25
Director/Board Member 66 2018-05-03
Director/Board Member 60 2022-05-04
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Buy 460 0.0007%
5/8/26 Buy 618 0.0009%
3/11/26 Sell 179 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+4.35%+4.23%+31.79% 47.86B
-0.83%-0.36%+43.66%+34.77% 44.46B
-0.84%+4.86%+10.92%+91.52% 41.85B
-1.10%-2.64%+331.49%+535.80% 41.34B
-0.62%+0.11%+1.12%+46.02% 30.04B
-2.07%+0.12%+24.39%+154.30% 17.59B
-6.08%-9.92% - - 15.6B
-3.55%+1.95%+21.97%+38.83% 15.69B
-0.78%+9.46%-8.96% - 13.93B
-2.73%+1.43%+84.58%+38.93% 13.61B
Average -1.78%+1.97%+57.05%+121.49% 28.2B
Weighted average by Cap. -1.19%+1.49%+68.09%+135.80%

Financials

2026 *2027 *
Net sales 7.13B 8.64B 7.58B 6.52B 12.18B 828B 12.27B 85.63B 33.2B 422B 32.45B 31.74B 1,368B 7.95B 9.64B 8.46B 7.27B 13.59B 923B 13.69B 95.52B 37.03B 471B 36.2B 35.4B 1,526B
Net income 1.22B 1.48B 1.3B 1.11B 2.08B 142B 2.1B 14.65B 5.68B 72.18B 5.55B 5.43B 234B 1.44B 1.74B 1.53B 1.31B 2.45B 167B 2.47B 17.26B 6.69B 85.04B 6.54B 6.4B 276B
Net Debt 2.79B 3.39B 2.97B 2.55B 4.77B 324B 4.81B 33.56B 13.01B 165B 12.72B 12.44B 536B 2.69B 3.25B 2.86B 2.45B 4.59B 312B 4.62B 32.25B 12.5B 159B 12.22B 11.95B 515B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,141
Date Price Change Volume
26-09-23 CHF 561.80 -0.18% 100,593
26-09-22 CHF 562.80 +2.55% 101,345
26-09-21 CHF 548.80 +0.59% 75,753
26-09-18 CHF 545.60 +0.11% 268,844
26-09-17 CHF 545.00 +1.23% 156,031
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
561.80CHF
Average target price
688.17CHF
Spread / Average Target
+22.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock